SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
DURUS LIFE SCIENCES MASTER FUND LTD
(Last) (First) (Middle)
C/O INT'L. FUND SERVICES (IRELAND) LTD.
3RD FL., BISHOPS SQUARE, REDMONDS HILL
(Street)
DUBLIN 2, IRELAND
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ALLOS THERAPEUTICS INC [ ALTH ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2002
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock(1) 01/28/2003 P 1,500 A $6.4676 4,340,100 D
Common Stock 01/29/2003 P 2,200 A $6.5325 4,342,300 D
Common Stock 01/29/2003 S 500 D $6.49 4,341,800 D
Common Stock 01/30/2003 P 26,400 A $6.3287 4,368,200 D
Common Stock 01/30/2003 S 10,000 D $6.2907 4,358,200 D
Common Stock 01/30/2003 P 10,000 A $6.3435 4,368,200 D
Common Stock 01/31/2003 P 29,400 A $6.698 4,397,600 D
Common Stock 01/31/2003 S 25,100 D $6.325 4,372,500 D
Common Stock 01/31/2003 P 10,000 A $6.3849 4,382,500 D
Common Stock 01/31/2003 P 20,000 A $7.02 4,402,500 D
Common Stock 01/31/2003 P 10,000 A $6.4069 4,412,500 D
Common Stock 02/03/2003 P 10,000 A $6.8418 4,422,500 D
Common Stock 02/03/2003 S 6,000 D $6.8608 4,416,500 D
Common Stock 02/04/2003 P 14,100 A $6.6732 4,430,600 D
Common Stock 02/04/2003 S 6,900 D $6.6633 4,423,700 D
Common Stock 02/05/2003 P 22,700 A $6.3692 4,446,400 D
Common Stock 02/05/2003 P 5,000 A $6.312 4,451,400 D
Common Stock 02/05/2003 P 10,000 A $6.312 4,461,400 D
Common Stock 02/06/2003 P 46,800 A $6.1918 4,508,200 D
Common Stock 02/07/2003 P 43,700 A $6.208 4,551,900 D
Common Stock 02/07/2003 S 100 D $6.1 4,551,800 D
Common Stock 02/10/2003 P 8,100 A $5.9998 4,559,900 D
Common Stock 02/10/2003 S 2,400 D $6.2517 4,557,500 D
Common Stock 02/11/2003 P 26,700 A $5.8314 4,584,200 D
Common Stock 02/12/2003 P 4,600 A $5.9315 4,588,800 D
Common Stock 02/13/2003 P 12,400 A $5.8811 4,601,200 D
Common Stock 02/14/2003 P 36,700 A $5.7748 4,637,900 D
Common Stock 02/18/2003 P 38,400 A $5.5733 4,676,300 D
Common Stock 02/18/2003 P 500 A $5.6 4,676,800 D
Common Stock(1) 02/18/2003 P 1,000 A $5.65 4,677,800 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Because the SEC's electronic filing system does not allow for the disclosure of more than 30 transactions on one Form 4, the Reporting Person is filing 21 simultaneous Forms 4 to report its reportable transactions, all of which together shall be deemed a single report filed on this date. This is the sixteenth Form 4 of the 21 filings.
Remarks:
This Form 4 is being filed by Durus Life Sciences Master Fund Ltd. (the "Master Fund") to report transactions that have previously been reported on Forms 4 filed August 22, 2003 by Durus Capital Management, LLC, the Master Fund's portfolio manager, and Scott Sacane, the managing member thereof. No new transactions are reported herein. The information on this form has been provided by International Funds Services (Ireland) Limited, the Master Fund's administrator. Pursuant to Instruction 5(a) of Form 4, the prices herein do not include commissions and other costs of execution.
DURUS LIFE SCIENCES MASTER FUND LTD. By: /s/ Leslie L. Lake, Director 10/30/2003
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.